HDHI

This ground breaking Nitric Oxide study was conducted in 2009 at the High Desert Heart Institute.  It involved 33 congestive heart failure patients who were all medically and pharmaceutically managed to the maximum meaning all patients were at maximum drug, supplemental oxygen, and therapy levels.

Unlike other clinical studies that isolate one item like L-arginine only, this study examined the synergistic effect of using multiple nutrients to properly nourish the endothelium to create therapeutic levels of nitric oxide for vascular improvements. ProArgi9+ was the product of choice and used by all study participants.

To scientifically test the effects of targeted nutritional support to the endothelium and how it could potentially impact cardiovascular health, extensive diagnostic testing was conducted over a 90 day period producing almost 7000 points of data. Each study participant was given two scoops of ProArgi-9+ in the morning and two scoops in the evening.

The results of this 90 day study were “remarkable” and are summarized below.  Many of the patients were able to resume normal living, reduce medication levels, eliminate drugs, and dramatically improve the quality of their lives.

6% decrease in CASP (Central Aortic Systolic Pressure)
8% reduction in Glucose levels
11% decrease in Creatine levels
13% decrease in Systolic BP
16% increase in Peripheral Blood Flow (ABI)
17% decrease in Diastolic BP
18% increase in HDL Cholesterol
25% decrease in C-reactive Protein
35% increase in Magnesium levels
40% decrease in Triglycerides
70% decrease in U. Micro Albumin
183% increase in Vitamin D levels
Platelet aggregation decreased significantly (no percentage given)
Bilirubin decreased significantly (no percentage given)
6 minute walk test increased dramatically (no percentage given)
Pulmonary Hypertension dramatically improved
Quality of life measurements significantly improved for all participants